自免疫性疾病中的免疫检查点调节失调:对治疗影响的叙述性审查
Diwan Mahmood Khan1, Rohit Kumar2, Mahavadi Sriharsha3
1Department of Microbiology, Varun Arjun Medical College & Rohilkhand Hospital, Shahjahanpur, IND.
Cureus
|December 19, 2025
概括
免疫检查点调节免疫反应. 本综述强调了用于诊断自身免疫性疾病的组织分析和生物标记面板,以及用于安全地重新平衡免疫力的分期疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
- 翻译医学是一种翻译医学.
背景情况:
- 免疫检查点平衡免疫反应,充当关键调节者.
- 自身免疫性疾病涉及失调的免疫检查点,包括弱抑制,过度的共同刺激,代谢/表观遗传变化和不协调的组织/血液发现.
- 目前的理解往往依赖于血液标记物,可能错过了关键的组织层面的洞察力.
研究的目的:
- 对自身免疫性疾病中免疫检查点调节失调的人类和转化研究进行审查.
- 强调基于组织的数据和先进的治疗策略的重要性.
- 提出一个生物标志物小组和免疫再平衡的分阶段治疗方法.
主要方法:
- 在PubMed/MEDLINE,Embase,Web of Science和Scopus (到2025年) 的综合文献综述.
- 优先考虑研究的重点是基于组织的数据,检查点激动剂,协同刺激阻塞和基于细胞的耐受性 (IL-2,CAR-Tregs,EVs).
- 分析免疫代谢因素,如乳酸,乳和铁死,影响检查点功能和调节性T细胞 (Tregs).
主要成果:
- 组织分析优于血液分析,用于追踪自身免疫性疾病活动.
- 免疫代谢应激,特别是乳酸驱动的过程,可以损害检查点功能 (PD-1/CTLA-4) 和Treg稳定性.
- 一个拟议的生物标记面板将病变免疫组织化学/空间映射与可溶性标记物和EV货物相结合.
结论:
- 建议采取分阶段的治疗策略:降低炎症/代谢负荷,恢复抑制性度,并提供Treg/EV支持.
- 安全考虑包括疫苗的时间,量身定制的剂量和复合面板,以区分疾病爆发和过度抑制.
- 未来的试验应以内型为先,以空间为基础,并以生物标志物为主,以实现持久和更安全的免疫再平衡.
相关概念视频
Autoimmune Disorders
1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Inflammatory Response
15.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.8K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
447
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
447
Inflammatory Bowel Disease IV: Pharmacological Management
427
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
427
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K


